Results 171 to 180 of about 65,523 (199)

Nucleos(t)ide Analog-Therapeutic Vaccination Switch: A Novel Approach for Safe and Effective Treatment Discontinuation in HBeAg (-) Chronic Hepatitis B Patients. [PDF]

Vaccines (Basel)
Akbar SMF, Mahtab MA, Rahim MA, Noor-E-Alam SM, Mahtab M, Moben AL, Begum R, Das DC, Guillen G, Yoshida O, Martinez IS, Hiasa Y, Khan S, Aguilar JC.   +13 more
europepmc   +1 more source

Predictive value of serum HBcrAg in antiviral therapy for chronic hepatitis B. [PDF]

Front Immunol
Wang S, Hao H, Deng W, Zhang L, Cao W, Zhang Z, Li X, Zhang Y, Wei X, Yao L, Gao Z, Wang S, Li M.   +12 more
europepmc   +1 more source

Efficacy and Metabolic Effects of Pegylated Interferon α-2b versus Nucleos(T)ide Analogues in Patients with Chronic Hepatitis B and Concomitant Metabolic Dysfunction-Associated Steatotic Liver Disease: A Retrospective Study. [PDF]

Hepat Med
Liu Y, Wang H, Zheng X, He C, Xie Y, Dai Y, Chen H, Liu Z, Chen S, Liang H.   +9 more
europepmc   +1 more source

HBsAg glycan isomer predicts on-treatment HBsAg decline in low-HBsAg chronic hepatitis B on nucleos(t)ide therapy. [PDF]

Virol J
Yokoyama D, Suda G, Ohara M, Tanaka T, Kitano S, Maehara O, Deng R, Fu Q, Yang Z, Yasuura N, Meno A, Kohya R, Kitagataya T, Kawagishi N, Nakai M, Sho T, Ohnishi S, Sakamoto N.   +17 more
europepmc   +1 more source

Letter: Defining the Incremental Predictive Value of HBsAg in Hepatocellular Carcinoma Risk Prediction, Authors' Reply. [PDF]

Aliment Pharmacol Ther
Guo YF, Guo C, Ji D, Niu XX.
europepmc   +1 more source

Prevalence of renal and bone risk factors and nucleos(t)ide analogue treatment among patients with chronic hepatitis B in the United States. [PDF]

J Manag Care Spec Pharm
Stead AE, Christoph MJ, Singer AW, Wang W, Hsiao A, Majethia S, Byrne S, Zachry W.   +7 more
europepmc   +1 more source

Nucleos(t)ide analogue therapy combined with pegylated interferon α-2b guided by the GOLDEN prediction model for functional cure of chronic hepatitis B: study protocol (GIFT project). [PDF]

BMJ Open
Chai S, Jiang J, Wang C, He Y, Jia X, Xi Q, Jing F, Chang L, Zhang W, Guo Y, Du F, Feng J, Chai Y, Cao Y, Li F, Zhang L, Chen S, Wang Y, Lin Y, Cao H, Zhang Y, Liang Y, Li F, Hao Y, Gao X, Li H, Zhang Y, Kang W.   +27 more
europepmc   +1 more source

Analysis of Viral Blips Through Week 192 of the DRIVE-FORWARD and DRIVE-AHEAD Phase 3 Studies of Doravirine-Based Regimens in Adults Living With Previously Untreated HIV-1. [PDF]

Open Forum Infect Dis
Molina JM, Orkin C, Paredes R, Xu ZJ, Su FH, Asante-Appiah E, Plank RM, Lahoulou R.   +7 more
europepmc   +1 more source